ID16856A - Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan - Google Patents

Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan

Info

Publication number
ID16856A
ID16856A IDP971466A ID971466A ID16856A ID 16856 A ID16856 A ID 16856A ID P971466 A IDP971466 A ID P971466A ID 971466 A ID971466 A ID 971466A ID 16856 A ID16856 A ID 16856A
Authority
ID
Indonesia
Prior art keywords
subazed
subditions
connected compounds
compounds
subazed subditions
Prior art date
Application number
IDP971466A
Other languages
English (en)
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ID16856A publication Critical patent/ID16856A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDP971466A 1996-05-03 1997-05-02 Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan ID16856A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1686196P 1996-05-03 1996-05-03

Publications (1)

Publication Number Publication Date
ID16856A true ID16856A (id) 1997-11-13

Family

ID=21779401

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971466A ID16856A (id) 1996-05-03 1997-05-02 Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan

Country Status (42)

Country Link
US (2) US6211222B1 (id)
EP (1) EP0912521B1 (id)
JP (1) JP3148254B2 (id)
KR (1) KR100339935B1 (id)
CN (2) CN1112359C (id)
AP (4) AP2001002304A0 (id)
AR (1) AR006906A1 (id)
AT (1) ATE292626T1 (id)
AU (1) AU725576B2 (id)
BG (1) BG64211B1 (id)
BR (1) BR9709051A (id)
CA (2) CA2389918A1 (id)
CO (1) CO4650038A1 (id)
CZ (1) CZ292825B6 (id)
DE (1) DE69732966T2 (id)
DZ (1) DZ2217A1 (id)
EA (1) EA002272B1 (id)
ES (1) ES2238079T3 (id)
GT (1) GT199700043A (id)
HK (1) HK1019443A1 (id)
HN (1) HN1997000046A (id)
HR (1) HRP970227B1 (id)
HU (1) HUP9902459A3 (id)
ID (1) ID16856A (id)
IL (2) IL126547A (id)
IS (1) IS4871A (id)
MA (1) MA24158A1 (id)
MY (1) MY132499A (id)
NO (1) NO312959B1 (id)
NZ (1) NZ332240A (id)
OA (1) OA10904A (id)
PE (1) PE64598A1 (id)
PL (1) PL329836A1 (id)
SK (1) SK148298A3 (id)
TN (1) TNSN97070A1 (id)
TR (1) TR199802202T2 (id)
TW (1) TW449585B (id)
UA (1) UA65536C2 (id)
UY (1) UY24532A1 (id)
WO (1) WO1997042174A1 (id)
YU (1) YU16397A (id)
ZA (1) ZA973804B (id)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
AP2001002304A0 (en) * 1996-05-03 2001-12-31 Pfizer Substituted indazole derivatives and related compounds
EP2223920A3 (en) * 1996-06-19 2011-09-28 Aventis Pharma Limited Substituted azabicyclic compounds
PT983249E (pt) * 1997-05-08 2002-08-30 Pfizer Prod Inc Procesos e intermediarios para a preparacao de derivados de indazole substituidos
IL126745A (en) * 1997-11-04 2003-09-17 Pfizer Prod Inc Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors
JP2001521926A (ja) * 1997-11-04 2001-11-13 ファイザー・プロダクツ・インク 治療上活性の化合物におけるカテコールのインダゾール生物学的等価物置換
ID24942A (id) * 1997-11-04 2000-08-31 Pfizer Prod Inc Senyawa terapi aktif yang berdasarkan penggantian bioisoster katekol dengan indazole pada inhibitor pde4
IL132407A0 (en) * 1998-10-21 2001-03-19 Pfizer Prod Inc Method for treating congestive heart failure
JP2000198734A (ja) * 1998-12-30 2000-07-18 Pfizer Inc 胃運動性減弱および関連疾患の治療のための運動性増強薬
US6362213B1 (en) 1999-12-23 2002-03-26 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
EP1244649B1 (en) * 1999-12-23 2005-03-02 Icos Corporation Cyclic amp-specific phosphodiesterase inhibitors
US7211594B2 (en) * 2000-07-31 2007-05-01 Signal Pharmaceuticals, Llc Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
US6953774B2 (en) 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation
BRPI0117198B1 (pt) 2001-12-14 2018-03-13 Merck Serono S.A. Usos de composição compreendendo um inibidor seletivo de uma isoforma 4 de fosfodiesterase
US20040034084A1 (en) * 2002-05-24 2004-02-19 Celgene Corporation Methods for using JNK inhibitors for treating or preventing disease-related wasting
US7196082B2 (en) * 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
US20050019366A1 (en) * 2002-12-31 2005-01-27 Zeldis Jerome B. Drug-coated stents and methods of use therefor
DE10318610A1 (de) 2003-04-24 2004-11-11 Elbion Ag 7-Azaindole und deren Verwendung als Therapeutika
US7601847B2 (en) 2004-10-26 2009-10-13 Wyeth Preparation and purification of 4-(indazol-3-yl)phenols
US20070004777A1 (en) * 2005-03-23 2007-01-04 Bhagwat Shripad S Methods for treating or preventing acute myelogenous leukemia
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2646902C (en) * 2006-04-21 2017-01-31 Centocor Inc. Cxcl13 antagonists and their use for the treatment of inflammatory diseases
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
BR112020009055A2 (pt) 2017-11-06 2020-11-03 Rapt Therapeutics, Inc. moduladores de receptor de quimiocina para tratamento de câncer positivo para vírus epstein barr

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994890A (en) * 1974-01-31 1976-11-30 Chugai Seiyaku Kabushiki Kaisha 1-Aminoalkyl, 3-phenyl indazoles
JPS5654437A (en) * 1979-10-09 1981-05-14 Konishiroku Photo Ind Co Ltd Direct positive image forming method
GB8707051D0 (en) * 1986-04-15 1987-04-29 Ici America Inc Heterocyclic carboxamides
JP2525286B2 (ja) * 1990-11-26 1996-08-14 日本原子力研究所 超耐熱性炭化ケイ素繊維の製造方法
TW223004B (id) * 1991-11-25 1994-05-01 Sumitomo Chemical Co
CA2131625A1 (en) * 1992-03-09 1993-09-16 Donald R. James Novel arylindazoles and their use as herbicides
US5444038A (en) * 1992-03-09 1995-08-22 Zeneca Limited Arylindazoles and their use as herbicides
SK279958B6 (sk) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation Zlúčeniny s protialergickým a protizápalovým účink
US5554620A (en) * 1993-09-14 1996-09-10 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
US5440038A (en) * 1993-12-07 1995-08-08 Miles Inc. Process for the purification of substituted 4-amino-1,2,4-triazine-5-ones
CN1050129C (zh) * 1994-10-20 2000-03-08 美国辉瑞有限公司 二环四氢吡唑并吡啶和其作为药物的应用
DE69516298T2 (de) * 1994-10-21 2000-12-28 Elisha Technologies Co. L.L.C., Moberly Korrosionsverhinderndes puffer-system für metallprodukte
AP2001002304A0 (en) * 1996-05-03 2001-12-31 Pfizer Substituted indazole derivatives and related compounds
PT983249E (pt) * 1997-05-08 2002-08-30 Pfizer Prod Inc Procesos e intermediarios para a preparacao de derivados de indazole substituidos

Also Published As

Publication number Publication date
TW449585B (en) 2001-08-11
JP3148254B2 (ja) 2001-03-19
HN1997000046A (es) 1997-06-26
HUP9902459A3 (en) 2001-10-29
IL126547A (en) 2003-03-12
CO4650038A1 (es) 1998-09-03
EP0912521A1 (en) 1999-05-06
ZA973804B (en) 1998-11-02
DE69732966D1 (de) 2005-05-12
UY24532A1 (es) 2000-09-29
MA24158A1 (fr) 1997-12-31
NO985095L (no) 1998-12-29
EA199800882A1 (ru) 1999-06-24
NO312959B1 (no) 2002-07-22
AU725576B2 (en) 2000-10-12
WO1997042174A1 (en) 1997-11-13
CZ349298A3 (cs) 1999-09-15
AP1146A (en) 2003-02-25
TR199802202T2 (xx) 1999-02-22
DZ2217A1 (fr) 2002-12-03
BR9709051A (pt) 1999-08-03
ATE292626T1 (de) 2005-04-15
BG102946A (en) 1999-11-30
AP0102304A0 (en) 1997-11-03
IL152083A0 (en) 2003-05-29
YU16397A (sh) 1999-12-27
AP9700975A0 (en) 1997-07-31
AP1147A (en) 2003-02-25
KR100339935B1 (ko) 2002-07-18
CZ292825B6 (cs) 2003-12-17
ES2238079T3 (es) 2005-08-16
CA2252982A1 (en) 1997-11-13
DE69732966T2 (de) 2005-09-08
CN1217714A (zh) 1999-05-26
AP2001002294A0 (en) 2001-12-31
UA65536C2 (en) 2004-04-15
PL329836A1 (en) 1999-04-12
TNSN97070A1 (fr) 2005-03-15
PE64598A1 (es) 1998-10-26
NO985095D0 (no) 1998-11-02
EA002272B1 (ru) 2002-02-28
JPH11508284A (ja) 1999-07-21
US6127398A (en) 2000-10-03
IL126547A0 (en) 1999-08-17
IS4871A (is) 1998-10-16
MY132499A (en) 2007-10-31
CA2252982C (en) 2002-10-08
CA2389918A1 (en) 1997-11-13
AU1937397A (en) 1997-11-26
HK1019443A1 (en) 2000-02-11
HRP970227A2 (en) 2000-12-31
CN1112359C (zh) 2003-06-25
HUP9902459A2 (hu) 1999-11-29
AR006906A1 (es) 1999-09-29
GT199700043A (es) 1998-10-02
CN1422849A (zh) 2003-06-11
US6211222B1 (en) 2001-04-03
EP0912521B1 (en) 2005-04-06
BG64211B1 (bg) 2004-05-31
NZ332240A (en) 2000-07-28
OA10904A (en) 2001-10-11
AP2001002304A0 (en) 2001-12-31
SK148298A3 (en) 2000-02-14
HRP970227B1 (en) 2002-06-30
KR20000010751A (ko) 2000-02-25

Similar Documents

Publication Publication Date Title
ID16856A (id) Turunan-turunan indazol yang disubstitusi dan senyawa-senyawa yang berhubungan
ID22426A (id) Ketobenzamida yang baru dan penggunaannya
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID19422A (id) Piridina dan bifenil tersubstitusi
NO993068L (no) Ny forbindelsesform
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
EG21153A (en) Use of oil and gasfield chemicals
IS5419A (is) Vatnshreinsunar- og vatnsmiðlunartæki
ID18679A (id) Penggunaan terapi lanjutan
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
FI960450A0 (fi) Lukitusteline
ID18682A (id) Asiltransferase dan plasma yang mengkodekan asiltransferase
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
DE69617446D1 (de) Verriegelungseinheit
ID20134A (id) Proses dan peralatan sintesis urea yang ditingkatkan
ID21770A (id) Plester yang mengandung felbinak
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin
ID19147A (id) Ksilanase dan pemakaiannya
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
EP0964691A4 (en) USE OF CONANTOKINE
ID18913A (id) Turunan turunan tienopiridin dan penggunaannya
ID21419A (id) Saklar dan peralatan saklar yang menggunakan saklar
ID17395A (id) Aluminosilikat berbentuk beraturan dan penggunaannya
KR960033565U (ko) 지압 및 쑥뜸 겸용 지압구
KR970059916U (ko) 콘센트 구조